GoodRx PE ratio GDRX

Share price divided by earnings per share over the last twelve months, since 2023.

Today, Oct 23, 2026: 88.5×
3-year median: 55.6×
Against its 3-year history: 66th; percentile: 0 is its lowest day, 100 its highest
3-year range: 20.8× to 264×
Peer median: 17.0×

GoodRx's PE ratio is 88.5× as of Oct 23, 2026: a share price of $3.54 against $0.04 of earnings per share over the last twelve months.

That is above its 3-year median of 55.6×, higher than on 66% of days in the last 3 years.

Over that time it ranged from 20.8× in Feb 2026 to 264× in Aug 2023.

The median for 10 application software stocks of a similar size is 17.0×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	88.5×	20.8×	93.3×
2025	30.6×	30.1×	99.6×
2024	160×	137×	166×
2023	168×	120×	264×

Against its peers

Companies in Software - Application nearest GoodRx's size, closest first, today.

Company	PE ratio
GDRXGoodRx	88.5×
LZLegalzoom.Com	77.7×
UPWKUpwork	12.5×
HSTMHealthstream	48.8×
EVEREverQuote	7.4×
TASKTaskUs	7.4×
EVTCEVERTEC	21.1×
YEXTYext	38.7×
MNTNMNTN	12.9×
INODInnodata	45.0×
NRDSNerdwallet	12.3×
Peer median	17.0×

Where GoodRx ranks

#48of 53Application software stocks with the lowest PE ratio

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on GoodRx

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.